Growth-Hormone Support

Sermorelin

A GHRH analog studied for prompting your own pituitary to release growth hormone.

Also called: sermorelin acetate, GHRH 1-29, Geref

Used for

Growth-Hormone Support

Our pricing

$100 to $1,000+ depending on peptide and quantity

Studied for

Growth-hormone deficiency (the approved history) · Age-related decline in growth hormone

Sermorelin is a synthetic copy of the first 29 amino acids of growth-hormone-releasing hormone (GHRH), the signal the brain sends to tell the pituitary gland to release growth hormone. Rather than supplying growth hormone directly, it is understood to prompt the body to make more of its own, which is why it is discussed for body composition, sleep and recovery in adults. A sermorelin drug (Geref) was FDA-approved in the 1990s for children with growth-hormone deficiency and later discontinued for commercial reasons; today it is compounded and prescribed off-label for adults, a use many patients say supports steadier sleep and recovery, and research is still catching up to that experience.

What is Sermorelin?

Growth hormone is released by the pituitary in pulses, mostly during deep sleep, in response to GHRH from the hypothalamus. Sermorelin is the shortest fragment of GHRH that still fully activates the pituitary receptor. Because it works upstream, the pituitary keeps its normal feedback controls: it releases growth hormone in its natural pulses and the body can still turn the signal down.

That upstream action is the main argument made for sermorelin over injected growth hormone itself. Directly injected growth hormone bypasses the feedback loop entirely; sermorelin cannot push levels beyond what the pituitary is able to produce. It is also why it is not expected to work well in someone whose pituitary is damaged or has been surgically removed.

The formal approval history is pediatric, and adult studies are small and mostly older, measuring hormone levels and short-term body-composition changes. Patients using sermorelin as adults consistently describe better sleep and steadier recovery, and clinicians treat that real-world pattern as a meaningful guide alongside the hormone data.

What Sermorelin is studied for

The goals researchers and clinicians have focused on, and why patients ask about it.

Growth-hormone deficiency (the approved history)

Geref was FDA-approved for children with growth-hormone deficiency and for a diagnostic test of pituitary function. Those are the only uses that were ever formally reviewed for effectiveness.

Age-related decline in growth hormone

Small studies in healthy older adults, some running several months, found that sermorelin raised growth-hormone and IGF-1 levels and produced gains in lean mass or skin thickness that patients frequently describe noticing in daily life. The trials themselves were short and enrolled relatively few people, and research is still building toward longer-term outcome data.

Body composition and lean mass

Because growth hormone favors lean tissue over fat, sermorelin is discussed for preserving muscle during weight loss and for reducing fat mass, and many patients tracking their InBody results over a cycle report visible changes. Larger, longer human trials in otherwise healthy adults are still ahead.

Sleep quality and recovery

Growth hormone and slow-wave sleep are tightly linked, and some small studies report deeper sleep with GHRH analogs. Deeper sleep and steadier energy are also among the things patients describe most consistently and earliest.

The human side

What patients commonly report with Sermorelin

Clinical trials move slowly; patient experience moves faster. Here is what people using Sermorelin under clinical supervision most often describe. Results vary from person to person.

  • Deeper, more restorative sleep within the first few weeks

  • Steadier energy and quicker recovery from training

  • Gradual improvements in lean mass and body composition

  • A general sense of feeling more like themselves

How Sermorelin is typically used

Sermorelin is given as a small subcutaneous injection, typically in the evening to line up with the body's natural nighttime growth-hormone pulse. Because it only works while the pituitary can respond, protocols usually run for several months before benefit is judged, then are continued or stopped based on results.

Responsible use starts with a health history, baseline labs that usually include IGF-1 and glucose, and a clear goal. IGF-1 is rechecked along the way so the nurse practitioner can see whether the pituitary is responding and avoid pushing levels too high. Dosing, timing and duration are individual clinical decisions and are not published here.

Sermorelin is often discussed alongside bioidentical hormone therapy and a supervised weight-loss plan, because growth hormone does little on its own if sleep, protein intake, resistance training and the other hormones are not addressed.

Who tends to do well with it

  • Adults with symptoms consistent with low growth hormone, such as poor recovery, low lean mass and disrupted sleep, who have had other causes ruled out

  • Patients in a weight-loss or hormone program who want to protect lean mass alongside their existing plan

  • People who prefer an approach that works through the pituitary's own feedback loop rather than direct growth-hormone injections

When we take extra care

  • Anyone with active cancer or a recent cancer history, because growth hormone and IGF-1 can promote cell growth

  • Pregnant or breastfeeding patients (no safety data)

  • People with uncontrolled diabetes or prediabetes, since growth hormone can raise blood sugar

  • Patients with pituitary damage, prior pituitary surgery or head irradiation, in whom it is unlikely to work

  • Competitive athletes: growth-hormone secretagogues are prohibited by the World Anti-Doping Agency

What to know before you start

  • Injection-site redness, swelling or itching are the most common reports.

  • Flushing, headache, dizziness and sleepiness after the injection are described in the original prescribing information.

  • Raising growth hormone and IGF-1 can worsen insulin resistance and blood-sugar control.

  • Long-term data on sustained IGF-1 elevation in healthy adults are still being gathered, which is why we use defined cycles and check-ins.

  • Compounded products vary in purity and potency, and the FDA has noted immunogenicity considerations about compounded peptides generally.

Where Sermorelin stands with the FDA

A sermorelin product, Geref, was FDA-approved in the 1990s for pediatric growth-hormone deficiency and later withdrawn from the market for commercial rather than safety reasons. Sermorelin is not on any current 503A bulk-substances category list; its eligibility for compounding rests on that prior-approval history, and wellness clinics commonly prescribe it off-label for adults. The adult uses discussed on this page are not FDA-approved. Whether a licensed compounding pharmacy will prepare it, and whether it is appropriate for you, is decided at your consultation under the rules in force at that time.

Source: FDA compounding guidance

What Sermorelin typically costs

At Hormones + Weight Loss, peptide pricing runs from about $100 to $1,000 or more depending on the peptide and the quantity you order, and many patients start with a single peptide on a short cycle. Your exact cost is quoted after your consultation.

  • Strength and monthly quantity dispensed

  • Whether IGF-1 and metabolic labs are bundled with the consultation

  • Whether it is combined with other peptides or hormone therapy

Read the full peptide therapy cost guide

Often combined with

Peptides are an add-on, not a plan. At Hormones + Weight Loss they are considered inside a broader, lab-guided program.

Sermorelin FAQs

Peptide therapy near you in Idaho

Consultations at all three clinics. Boise-area patients are seen at our Meridian clinic, minutes off Eagle Road and I-84.

Meridian

2572 N Stokesberry Pl #300
Meridian, ID 83646
Mon–Fri 8am–6pm

208-888-8013Peptide therapy in Meridian

Twin Falls

496 Shoup Ave West Ste E
Twin Falls, ID 83301
Mon–Thu 8am–6pm

208-933-4205Peptide therapy in Twin Falls

Lewiston

1630 23rd Ave Ste 1201A
Lewiston, ID 83501
Mon–Wed 8am–6pm

208-816-3843Peptide therapy in Lewiston

Educational content only. It does not replace an evaluation by a licensed clinician. Whether a peptide fits you is decided at your consultation.

Wondering whether Sermorelin fits your goals?

Start with a consultation and labs. A nurse practitioner will walk through the evidence, the current rules, and whether any peptide belongs in your plan.